MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.13529

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.

Alber Jessica, Bouwman Femke, den Haan Jurre, Rissman Robert A, De Groef Lies, Koronyo-Hamaoui Maya, Lengyel Imre, Thal Dietmar Rudolf, Alzheimer's Association ISTAART “The Eye as a Biomarker for AD” Professional Interest Area

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

There is emerging evidence that amyloid beta protein (Aβ) and tau-related lesions in the retina are associated with Alzheimer's disease (AD). Aβ and hyperphosphorylated (p)-tau deposits have been described in the retina and were associated with small amyloid spots visualized by in vivo imaging techniques as well as degeneration of the retina. These changes correlate with brain amyloid deposition as determined by histological quantification, positron emission tomography (PET) or clinical diagnosis of AD. However, the literature is not coherent on these histopathological and in vivo imaging findings. One important reason for this is the variability in the methods and the interpretation of findings across different studies. In this perspective, we indicate the critical methodological deviations among different groups and suggest a roadmap moving forward on how to harmonize (i) histopathologic examination of retinal tissue; (ii) in vivo imaging among different methods, devices, and interpretation algorithms; and (iii) inclusion/exclusion criteria for studies aiming at retinal biomarker validation.

Для цитирования: Alber Jessica, Bouwman Femke, den Haan Jurre, Rissman Robert A, De Groef Lies, Koronyo-Hamaoui Maya, Lengyel Imre, Thal Dietmar Rudolf, Alzheimer's Association ISTAART “The Eye as a Biomarker for AD” Professional Interest Area. Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023. DOI: 10.1002/alz.13529.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.